Cargando…

Efficacy and safety of travoprost 0.004%/timolol 0.5% fixed combination as transition therapy in patients previously on prostaglandin analog monotherapy

PURPOSE: To assess the safety and efficacy of transitioning patients whose intraocular pressure (IOP) had been insufficiently controlled on prostaglandin analog (PGA) monotherapy to treatment with travoprost 0.004%/timolol 0.5% fixed combination with benzalkonium chloride (TTFC). METHODS: This prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Vital Paulino, Moreira, Hamilton, Paolera, Mauricio Della, de Moraes Silva, Maria Rosa Bet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363305/
https://www.ncbi.nlm.nih.gov/pubmed/22654495
http://dx.doi.org/10.2147/OPTH.S30717